Status: Not yet recruiting
Prospective Real-World Evidence Study of the IpsiHand® System in Adult Stroke Survivors
This study focuses on monitoring real-world customers who have been prescribed the IpsiHand® as part of their rehabilitation post-stroke. This study aims to evaluate their progress over time, assessing motor recovery, functional independence in activities of daily living (ADLs), caregiver burden, and health economic outcomes.
Participants needed: 100
Trial details
Age: 18-85Biological sex: AllType: ObservationalSponsor: Neurolutions, Inc.Updated: Aug 29, 2025Duration: 2 Years
Eligibility criteria
Adult age 18-85 years. [+2]
Severe cognitive impairment that would impede utilization of IpsiHand® [+2]